Delivery of medicinal products for the treatment of cystic fibrosis as part of drug programs, including Ivacaftor and combinations of Ivacaftor, Tezacaftor, and Elexacaftor in specified quantities.
Awarded to:
Dostawa produktów leczniczych rozliczanych z pakietu programów lekowych dotyczących mukowiscydozy.